Our findings of TNC disease-free survival data was consistent with the study performed by Ni et al. in 2017, which reported a poor survival and prognosis of patients with high expression of TNC protein in prostate cancer biopsy tissues, through a histopathological study. This evidence concerns the gene TNC and Familial prostate cancer.